Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value 'Participation Criteria Collaborators No information provided Investigators No information provided 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change likely pertains to medical and healthcare-related publications and documentation.
    Difference
    19%
    Check dated 2024-05-22T08:35:41.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated primary completion date for the clinical trial involving Autologous Stem Cell Transplantation with Nivolumab in Patients with Multiple Myeloma.
    Difference
    0.1%
    Check dated 2024-05-09T06:25:26.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Summary
    The webpage has recently updated the status of the study from Unknown to Active, not recruiting. This change indicates that the study is now actively ongoing but not currently enrolling new participants.
    Difference
    7%
    Check dated 2024-05-07T20:41:43.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:44:51.000Z thumbnail image

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.